Navigation Links
Which Pharmacy Chain Offers GermBullet® Inhaler to Fight Exposure to Cold and Flu Viruses and Bacteria?
Date:2/16/2011

BOCA RATON, Fla., Feb. 16, 2011 /PRNewswire/ -- One of America's two largest drug store chains has a special GermBullet® dispenser on its pharmacy counters in nearly 3,000 stores.  

To help introduce this amazing new 100% organic product, GermBullet is giving away through March 4 thousands of its bullet-shaped nasal inhalers that help defend against cold and flu viruses and bacteria.  Visit www.germbullet.com.

"If you are first to identify GermBullet at any one of the 3,000 display locations, we will send you two GermBullets at no charge. That's nearly a $20 value," said Jim Whidden, vice president of Flu & Cold Defense, LLC, makers of the GermBullet. "Visit the two largest drug stores near you, and if you find a GermBullet display on the pharmacy or checkout counter like the middle one shown at http://www.germbullet.com/pos.php. Just email the drug store name, address and zip and your name, address and zip to wincontest@germbullet.com.  If you are the first to identify that store, you will win two free GermBullets. Those who are not the first will have their entries placed in a drawing for GermBullets. If you do not find any stores with GermBullet, then email us at wincontest@germbullet.com, tell us the names and locations of two stores that you visited, and we will enter you in the drawing."

The GermBullet nasal inhaler contains a proprietary broad-spectrum germ-fighting formula of eleven certified organic or wild-grown botanicals.  The pocket size, easy-to-use vapor inhaler has 100% organic ingredients and does not contain alcohol, zinc, synthetics, artificial fragrances, fillers, extenders or preservatives.

GermBullet is safe with a 25-year history of usage in liquid format available at www.nsaro
'/>"/>

SOURCE GermBullet
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
2. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
3. Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors Orders
4. Prostate Cancer Treatment Expert Dr. David Samadi, MD Discusses Study Which Found That Low-Income Men Had High-Risk Prostate Cancer Tumors
5. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
6. Mindset Media Study Reveals Which Independent Voters Favor Obama Vs. McCain
7. Going Beyond Spa Day: Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits
8. New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
9. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
10. Osteoarthritis: Which Treatments Work and Which Dont?
11. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  AcelRx Pharmaceuticals, ... that results from the  IAP310 study have been ... (RAPM), a peer-reviewed journal with broad, multidisciplinary ... trial evaluating the safety and efficacy of Zalviso, ... system (SSTS), for the treatment of post-operative pain ...
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , Oct. 20, 2014  PneumRx, Inc. ( www.pneumrx.com ... today announced completion of enrollment in their RENEW Study, ... Study is the FDA-approved IDE pivotal trial for the ... It was anticipated that the study, which ... would take until the end of 2014 to enroll ...
Breaking Medicine Technology:AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... officials on Monday officially tightened guidelines for health workers treating ... exposure and use of a respirator at all times. ... issue the tougher rules after two Dallas nurses contracted Ebola ... United States, Liberian national Thomas Eric Duncan. Nina Pham is ...
(Date:10/20/2014)... 20, 2014 The newly updated Worldwide ... of thousands of facts, figures and forecasts on the ... medical sector forecast categories the Worldwide Medical Market ... and national views on the worldwide medical market to ... report gives you data for 2010-2019, covering each country ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is ... repair a damaged mitral valve as the heart continues ... by Abbott Vascular , is designed to treat ... in which the heart’s mitral valve leaflets fail to ... heart’s left ventricle into the left atrium. The heart ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ASCNYC ... organization that helps New Yorkers living with HIV/AIDS ... toward health, housing, recovery and self-sufficiency. Each year, ... the local community through their tireless efforts. , ... Marc Shapses , has been selected as this ...
(Date:10/20/2014)... 2014 T.E.N., a technology and ... today that William H. Murray, renowned author and ... Luminary Leadership Award winner. Presented annually, the ISE® ... outstanding leader and industry practitioner for his or ... the information security industry. , Formerly with IBM, ...
Breaking Medicine News(10 mins):Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
... Marshall Erdman &,Associates (Erdman) was rated ... 2008 Construction & Design Survey. The survey,compares ... it,examines year-over-year sales, contracted square footage fluctuations, ... number of architects, engineers,and interior designers., ...
... important international relationships is top of the agenda ... Dr Raisa Monteiro, when she meets with leading ... One of two Australian life scientists chosen from ... prestigious 2008 Advancing BioBusiness Award, Russian-born Dr Monteiro ...
... HILL, N.C., March 27 Successful alliances that,lead ... each partner,company are contingent on the selection of ... efforts orient themselves towards,alliance by first articulating the ... using particular selective criteria., Best Practices, LLC,s ...
... Leading Developer of Practice Information Management Software Introduces Comprehensive Patient ... ... Back-Up, DALLAS, March 27 Eklin ... and,Communications System) and Practice Management software for veterinary care,(VIA(R)), is showcasing ...
... Lead Product Candidate, INTERLEUKIN-7, currently in ... cancer, PRINCETON, N.J. and PARIS, March 27 ... protein,production company, announced today that it has entered ... a clinical stage,biopharmaceutical company focused on research and ...
... LLC,( http://www.homeguardian.us/ ) has announced the release of ... status of seniors in their,homes while enabling professional ... the detection of falls, which constitute the largest,cause ... the United States., The systems were developed ...
Cached Medicine News:Health News:'Modern Healthcare' Names Marshall Erdman Nation's Top Design-Build Company 2Health News:DendriMed scientist seeks to fast-track success 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3Health News:Laureate Announces Second Manufacturing Agreement with Cytheris 2Health News:Laureate Announces Second Manufacturing Agreement with Cytheris 3Health News:Home Guardian Releases Innovative Sensor System to Keep Seniors Safe 2
... RiOs systems produce Type III, laboratory-grade pure ... are fed directly with potable tap water ... compact system design that is easy to ... the water produced at a low operating ...
... 10,400 more samples than traditionally-insulated freezers, ... panel technology maximizes storage capacity. Freezer ... compartments; two adjustable-height shelves included. Patented ... energy consumption and extends compressor life. ...
... The NU-5510 DHD AutoFlow Direct ... HEPA filtration guarantying the greatest control ... cycles, both at 95C wet decontamination ... are exceptionally useful for cell line ...
... Simple, economical, moderate-sized CO2 incubator with ... with glass inner door, HEPA filtered ... minimize sample exposure. Simple, large character ... IR CO2 sensing and mulitple temperature ...
Medicine Products: